Cellectis S.A. Statistics
NASDAQ: CLLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.9209-0.0789 (-7.89%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Cellectis S.A. by the numbers
Cellectis S.A. has a market capitalization of $92.8 million based on 72.73M shares outstanding. With trailing EPS of $-1.26, Cellectis S.A. is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 25.3% below its 50-day average and 67.7% below its 200-day average.
Average daily trading volume is 115.00K shares, or about $105,900 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
CLLS valuation vs. peer median
| Metric | CLLS | Peer median | Difference |
|---|---|---|---|
| Market cap | $92.76M | $94.23M | -2% |
| Avg. volume | 115.00K | 739.73K | -84% |
Peer median across 8 companies: DERM, CATX, NTHI, NRXP, PDSB, NBP, UNCY, CPIX.
Valuation
- Market cap
- $92.76M
- Price / sales (latest FY)
- 1.27
- EPS (TTM)
- $-1.26
- Shares outstanding
- 72.73M
Price and trading
- Previous close
- 0.9998
- Open
- 0.99
- Day range
- 0.9028 – 0.9957
- 52-week range
- 0.881 – 5.45
- 52-week change
- -80.36%
- Beta
- —
- Volume
- 52.63K
- Average volume
- 115.00K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 92.76M
- Forward Pe
- -1.67
- Eps
- -1.26
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 5.45
- Week52 Low
- 0.88
- Avg Volume
- 115.00K
- Shares Outstanding
- 72.73M
- Ma50
- 1.23
- Ma200
- 2.85
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -83.10%
- Pct From52w Low
- 4.53%